37LOW

ENL

ENLITIC CDI FORUS [ENL]
Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.
Healthcare · ASX Small Cap
$0.0070 +0.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical73
Catalyst50
Sentiment50
Fundamental51
Momentum36
Risk Gate24
Get alerts when ENL's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track ENL — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is picking up steam
  • Volume surging at 5.2x normal while price falls — heavy selling pressure
  • On a tear — up 16.7% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Critical cash runway (0.9 quarters)
  • Low P/S ratio (1.5x)
  • Strong revenue growth (+118%)
  • Near 52-week low (1% of range)
  • Micro-cap ($5-20M) - high risk
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 77% over the past year
  • Revenue growing at +118% — the top line is moving in the right direction
  • Altman Z-Score distress zone (-0.93 < 1.81, low-confidence approx)
  • Penny stock risk ($0.007)
  • Beneish M-Score -1.07 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.95%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ENL
"What's driving ENL's score?" "How does ENL compare to peers?" "Key risks for ENL?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Data Migration Contract with Penn Medicine
NONE Corporate Governance Statement & Appendix 4G
NONE Change of Director's Interest Notice
LOW Appendix 4E & 2025 Annual Report

Recent ASX Announcements

2026-03-22 Data Migration Contract with Penn Medicine PRICE SENSITIVE
2026-02-26 Corporate Governance Statement & Appendix 4G
2026-02-26 Appendix 4E & 2025 Annual Report PRICE SENSITIVE
2026-02-10 Change of Director's Interest Notice
2026-02-10 Change of Director's Interest Notice

Key Metrics

$5.8M
Market Cap
2.6M
Avg Volume
5.2x
Vol Ratio
$0.01 — $0.08
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-177.1%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 89%
LLeader vs LaggardlaggardRS: -14
IInstitutional SponsorshipweakInst: 8%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #102 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:ENL vs ATXENL vs PNVENL vs IMM
Scout Pro — Deeper Analysis for ENL
Try Pro free for 30 days
Share this analysis

Track ENL and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required